Page 27 - Read Online

Page 8 of 10 Mimouni et al. Rare Dis Orphan Drugs J 2024;3:17 https://dx.doi.org/10.20517/rdodj.2024.06

Authors’ contributions
Made substantial contributions to the conception of the perspective article: Mimouni Y, Julkowska D,
Halftermeyer J, Adam P, Moreau C, Petton Y, Rath A, Favresse R, Tumiene B
Performed data acquisition: Halftermeyer J, Rath A
Performed data analysis and interpretation: Halftermeyer J, Mimouni Y, Rath A, Tumiene B

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work is supported by funding from the European Union’s Horizon 2020 research and innovation
programme under the EJP RD COFUND-EJP N° 825575.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2024.

REFERENCES
1. EJP RD. Project structure. The European joint programme on rare diseases: presentation. Available from: https://www.ejprarediseases.
org/what-is-ejprd/project-structure/ [Last accessed on 17 Jun 2024].
2. IRDiRC. Who we are. Introduction to the international rare diseases research consortium (IRDiRC). Available from: https://irdirc.org/
who-we-are-2/ [Last accessed on 17 Jun 2024].
3. IRDiRC. Visions and goals. Available from: https://irdirc.org/about-us/vision-goals/ [Last accessed on 17 Jun 2024].
4. EJP RD. What is EJP RD? Governance. Available from: https://www.ejprarediseases.org/what-is-ejprd/governance/ [Last accessed on
17 Jun 2024].
5. IRDiRC. Scientific committees. Available from: https://irdirc.org/scientific-committees/ [Last accessed on 17 Jun 2024].
6. RE(ACT) congress and IRDiRC conference 5-7 March 2025 Brussels. Available from: https://www.react-congress.org/ [Last accessed
on 17 Jun 2024].
7. EJP RD. Innovation management toolbox. Available from: https://imt.ejprarediseases.org/ [Last accessed on 17 Jun 2024].
8. Hechtelt Jonker A, Hivert V, Gabaldo M, et al. Boosting delivery of rare disease therapies: the IRDiRC orphan drug development
guidebook. Nat Rev Drug Discov 2020;19:495-6. DOI
9. EURORDIS. Who we are. Available from: https://www.eurordis.org/who-we-are/our-vision-mission/ [Last accessed on 17 Jun 2024].
10. EURORDIS. Who we are - projects and partnerships - EJP on RD. Available from: https://www.eurordis.org/projects/ejp-on-rd/ [Last
accessed on 17 Jun 2024].
11. The National Mirror Groups (NMGs). European joint programme on rare diseases. Available from:: https://www.youtube.com/
watch?v=BbGjlsG0-RE [Last accessed on 17 Jun 2024].
12. EJP RD. Funded projects. Available from: https://www.ejprarediseases.org/our-actions-and-services/funding-opportunities/funded-
projects/. [Last accessed on 17 Jun 2024].
13. EJP RD. Short guide on patient partnerships in rare diseases research projects. Available from: https://www.ejprarediseases.org/wp-
content/uploads/2021/03/SHORT-GUIDE-ON-PATIENT-PARTNERSHIPS-IN-RARE-DISEASE-RESEARCH-PROJECTS.pdf [Last
accessed on 17 Jun 2024].
14. EJP RD. Patients’ training. https://www.ejprarediseases.org/our-actions-and-services/training-and-education/patients-training/ [Last
accessed on 17 Jun 2024].
15. EJP RD. Networking support scheme (NSS) call. Available from: https://www.ejprarediseases.org/our-actions-and-services/funding-
opportunities/calls/networking-support/ [Last accessed on 17 Jun 2024].